Immediate Impact
3 from Science/Nature 51 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
2025 Standout
Works of Rajendra Pradhan being referenced
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rajendra Pradhan | 119 | 130 | 196 | 234 | 198 | 32 | 760 | |
| Stephen Krauss | 147 | 241 | 147 | 142 | 46 | 33 | 882 | |
| Rajendra Ramsamooj | 148 | 225 | 251 | 90 | 78 | 31 | 912 | |
| F. W. Ballardie | 243 | 63 | 218 | 150 | 466 | 37 | 905 | |
| Sonja Mandl–Weber | 100 | 223 | 510 | 79 | 111 | 27 | 933 | |
| Seigo Ueda | 37 | 369 | 124 | 331 | 48 | 48 | 728 | |
| Kelly J. Norsworthy | 67 | 310 | 437 | 136 | 86 | 41 | 980 | |
| Dongping Chen | 128 | 84 | 241 | 35 | 89 | 39 | 888 | |
| Morten Krogh Jensen | 96 | 160 | 155 | 63 | 32 | 24 | 709 | |
| Vesna Brglez | 141 | 89 | 181 | 149 | 260 | 43 | 760 | |
| Patrick J. Medina | 158 | 203 | 162 | 158 | 76 | 22 | 699 |
All Works
Loading papers...